Addressing the Silent Pandemic: Managing Antibiotic Overuse in India – Mains Specific

Antimicrobial Resistance (AMR) has emerged as a grave public health challenge in India, often referred to as a silent pandemic. The indiscriminate use of antibiotics in clinical settings and the agricultural sector is fueling the rise of superbugs, rendering essential medicines ineffective. This article explores the systemic issues behind antibiotic misuse, the governance challenges in regulation, and the urgent need for a One Health approach to preserve the efficacy of life-saving drugs for future generations while balancing accessibility with responsible consumption.

Introduction

Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi, and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness, and death. In India, the ease of over-the-counter access to antibiotics, coupled with incomplete treatment courses and their prophylactic use in livestock, has accelerated the development of drug-resistant pathogens, posing a significant threat to global health security.

Why in News?

Recent public health discourse and data analysis highlight a concerning trend in the excessive prescription and consumption of antibiotics across India. This surge is linked to rising incidences of multi-drug resistant infections, prompting health experts and policy think-tanks to call for stringent regulation, rational prescription practices, and enhanced surveillance of antibiotic sales to mitigate the growing threat of AMR.

AMR is deeply connected to the static UPSC subject of Science and Technology, specifically the sub-topic of Biotechnology and Public Health. It also overlaps with Governance under the 'Health' sector. The concept involves the biological evolution of microorganisms under selective pressure from antibiotics. UPSC often tests the conceptual understanding of how bacteria develop resistance (genetic mutation and horizontal gene transfer) and the policy-level interventions required to control it, such as the One Health framework.

The World Health Organization (WHO) leads global efforts through the Global Antimicrobial Resistance and Use Surveillance System (GLASS). In India, the National Centre for Disease Control (NCDC) under the Ministry of Health and Family Welfare spearheads the National Action Plan on AMR (NAP-AMR). The Central Drugs Standard Control Organisation (CDSCO) regulates the manufacture and sale of drugs, which is crucial for monitoring antibiotic distribution. Traps often involve confusing the roles of these bodies or incorrectly attributing the oversight of drug regulations to the wrong ministry.

Background of the Issue

Antibiotics are medicines used to prevent and treat bacterial infections. Their discovery revolutionized medicine in the 20th century. However, overuse in humans (for viral infections like the common cold) and animals (to promote growth or prevent disease in crowded conditions) has led to the survival and proliferation of resistant strains. India’s high burden of infectious diseases makes it particularly vulnerable, as the failure of standard antibiotics can lead to high mortality rates in common surgeries and procedures.

What Has Happened Recently?

There is an increasing focus on the "rational use of medicines." Medical professional bodies and health departments are being urged to implement strict prescription-only policies. Furthermore, the agricultural sector is under scrutiny for the non-therapeutic use of antibiotics in poultry and cattle, which enters the human food chain and contributes to environmental contamination through water and soil.

Key Facts and Data

  • AMR is a key priority under the G20 health agenda.
  • The WHO recognizes AMR as one of the top ten global public health threats facing humanity.
  • India’s National Action Plan for AMR aims to reduce the need for antibiotics through better infection prevention and control.

UPSC Syllabus Relevance

Prelims

Science and Technology: Health and Biotechnology.

Current Affairs: Global health initiatives, pandemic preparedness, and national health policies.

Mains

GS Paper II: Issues relating to development and management of Social Sector/Services relating to Health.

GS Paper III: Science and Technology (Developments and applications).

Essay

Themes: The ethics of medical practice, the balance between development and environment, and the future of global health.

Interview

The topic is vital for discussing India's healthcare infrastructure, the challenges of regulating the pharmaceutical market, and international cooperation in health governance.

Detailed Explanation

The issue of AMR is multifaceted, involving clinical, agricultural, and environmental dimensions.

Clinical: Patients often self-medicate or purchase antibiotics without a prescription. Doctors, under pressure, often over-prescribe broad-spectrum antibiotics.

Agricultural: The use of antibiotics as growth promoters in livestock is a major contributor to the spread of resistance in the environment.

Environmental: Improper disposal of pharmaceutical waste leads to high concentrations of antibiotics in water bodies, creating 'hotspots' for resistant bacteria.

Governance: India faces the challenge of balancing the accessibility of affordable drugs for the poor with the necessity of restricting access to prevent misuse.

Important Dimensions

Governance dimension

Regulation of pharmacies and monitoring of the pharmaceutical supply chain are central. The implementation of 'Schedule H' drugs regulation requires better enforcement by state-level drug controllers.

Environmental dimension

Pharmaceutical waste management in industrial clusters is a major concern. Residues in water can lead to the horizontal transfer of resistance genes between bacteria.

Benefits / Significance

Strengthening AMR control will reduce healthcare costs, improve the success rates of surgeries, and ensure that basic infections do not turn into life-threatening emergencies.

Challenges / Concerns

Lack of awareness among the general population, the high cost of newer generation antibiotics, and the difficulty in monitoring the vast, decentralized retail medicine market in India.

Government Initiatives / Institutional Measures

  • National Action Plan on AMR (NAP-AMR) launched in 2017.
  • Red Line Campaign: A government initiative to highlight the dangers of misusing antibiotics.
  • FSSAI norms: Regulations on antibiotic residues in food products.

International Examples / Global Best Practices

The 'One Health' approach adopted by the Tripartite alliance (WHO, FAO, WOAH) is the global gold standard, emphasizing the interconnection between human, animal, and environmental health.

Prelims-Oriented Points

  • What is the 'Red Line' campaign? It is an awareness drive against the misuse of antibiotics.
  • Are all antibiotics 'Schedule H'? No, specific categories like H and H1 are strictly regulated.
  • Linkage: AMR is not a result of a specific pathogen but a broad biological phenomenon.

Mains-Oriented Analysis

Discuss the 'One Health' approach in the Indian context. How can we integrate medical, veterinary, and environmental surveillance? Emphasize the role of the state in regulating the pharmaceutical industry while incentivizing the development of new antibiotics.

Possible UPSC Questions

Prelims

1. Which of the following best describes the 'One Health' approach in the context of Antimicrobial Resistance (AMR)?

A. A focus solely on developing new vaccines for humans.

B. A strategy that integrates human, animal, and environmental health sectors.

C. A policy for the exclusive use of antibiotics in hospitals.

D. A program to ban all antibiotic production globally.

Answer: B

Mains

1. Antimicrobial Resistance (AMR) is often described as a silent pandemic. Discuss the socio-economic implications of AMR for a developing nation like India and suggest a multi-sectoral strategy to combat this challenge.

Way Forward

India must move towards a robust prescription-only system, enhance public awareness, and invest in rapid diagnostic tools that help clinicians distinguish between viral and bacterial infections, thereby reducing unnecessary antibiotic usage.

Conclusion

Combating AMR requires a paradigm shift in how society views antibiotics—moving from seeing them as easily available commodities to viewing them as precious, finite resources. A concerted effort involving policy enforcement, public education, and scientific innovation is essential to safeguard public health for future generations.

Scroll to Top